New 3D-Guided radiation boost aims to hit prostate tumors more precisely
NCT ID NCT05322356
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small study tests whether a 3D ultrasound system can help doctors place extra radioactive iodine seeds precisely into prostate tumors. Fifteen men with low- or intermediate-risk prostate cancer will receive the boost during standard brachytherapy. The main goal is to see if the seeds land in the right spot, not yet to measure cancer control or side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- iodine-125 radioactive implant
- What this could lead to
- If successful, this could improve precision in delivering radiation boosts to prostate tumors, potentially reducing side effects.
- What could go wrong
- This is a very small, early feasibility study with only 15 participants. It is not designed to prove effectiveness or safety, and the approach may not work as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW OR FAVORABLE INTERMEDIATE RISK PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Isabelle Boudry
Grenoble, 38043, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?